Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
    • Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
      • 1-Minute Consult
      • Commentary
      • Current Drug Therapy
      • Editorial
      • Guidelines to Practice
      • Interpreting Key Trials
      • Letter to the Editor
      • Review
      • Smart Testing
      • Symptoms to Diagnosis
      • The Clinical Picture
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
  • COVID-19
    • Curbside Consults Overview
    • Pulmonary/ICU
    • Patient Subsets & Specific Organ Involvement
    • Therapies
    • Imaging & Procedures
    • Patients with Underlying Disease
    • Virus Background & Testing
    • Healthcare System Practice
  • Conference Coverage
    • ASH Annual Meeting
    • AHA Sessions 2020
    • IDWeek 2020
    • CHEST 2020
    • ADA 2020
    • ACC 2020
  • Advertise
    • Media Kit
    • Contact
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
    • Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
  • COVID-19
    • Curbside Consults Overview
    • Pulmonary/ICU
    • Patient Subsets & Specific Organ Involvement
    • Therapies
    • Imaging & Procedures
    • Patients with Underlying Disease
    • Virus Background & Testing
    • Healthcare System Practice
  • Conference Coverage
    • ASH Annual Meeting
    • AHA Sessions 2020
    • IDWeek 2020
    • CHEST 2020
    • ADA 2020
    • ACC 2020
  • Advertise
    • Media Kit
    • Contact
Symptoms to Diagnosis

Fever in a lung transplant recipient

Graham Walter, MD, Hanna Lyubetska, MD, MSc and Aditya Sharma, MD, FRCPC
Cleveland Clinic Journal of Medicine December 2020, 87 (12) 735-741; DOI: https://doi.org/10.3949/ccjm.87a.19132
Graham Walter
Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanna Lyubetska
Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lyubetsh@myumanitoba.ca
Aditya Sharma
Department of Internal Medicine, Section of General Internal Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading
PDF extract preview

You do not have access to the full text of this article, the first page of the PDF of this article appears above.

REFERENCES

  1. ↵
    1. Skinner J,
    2. Yankey B,
    3. Shelton BK
    . Hemophagocytic lymphohistiocytosis. AACN Adv Crit Care 2019; 30(2):151–164. doi:10.4037/aacnacc2019463
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Boisseau M,
    2. Lambotte O,
    3. Galicier L, et al
    . Epstein-Barr virus viral load in human immunodeficiency virus-positive patients with reactive hemophagocytic syndrome. Infect Dis (Lond) 2015; 47(6):423–427. doi:10.3109/00365548.2015.1007475
    OpenUrlCrossRef
  3. ↵
    1. Rivière S,
    2. Galicier L,
    3. Coppo P, et al
    . Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients. Am J Med 2014; 127(11):1118–1125. doi:10.1016/j.amjmed.2014.04.034
    OpenUrlCrossRefPubMed
  4. ↵
    1. Marik PE,
    2. Taeb AM
    . SIRS, qSOFA and new sepsis definition. J Thorac Dis 2017; 9(4):943–945. doi:10.21037/jtd.2017.03.125
    OpenUrlCrossRefPubMed
  5. ↵
    1. Dioverti MV,
    2. Razonable RR
    . Cytomegalovirus. Microbiol Spectr 2016; 4(4). doi:10.1128/microbiolspec.DMIH2-0022-2015
    OpenUrlCrossRef
  6. ↵
    1. Ljungman P,
    2. Griffiths P,
    3. Paya C
    . Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002; 34(8):1094–1097. doi:10.1086/339329
    OpenUrlCrossRefPubMed
  7. ↵
    1. Verbeeck J,
    2. Van Kerschaver E,
    3. Wollants E,
    4. Beuselinck K,
    5. Stappaerts L,
    6. Van Ranst M
    . Detection of perinatal cytomegalovirus infection and sensorineural hearing loss in Belgian infants by measurement of automated auditory brainstem response. J Clin Microbiol 2008; 46(11):3564–3568. doi:10.1128/JCM.00757-08
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Ruuskanen O,
    2. Lahti E,
    3. Jennings LC,
    4. Murdoch DR
    . Viral pneumonia. Lancet 2011; 377(9773):1264–1275. doi:10.1016/S0140-6736(10)61459-6
    OpenUrlCrossRefPubMed
  9. ↵
    1. Nakanishi M,
    2. Yoshida Y,
    3. Takeda N, et al
    . Community-acquired pneumonia distinguished from influenza infection based on clinical signs and symptoms during a novel (swine) influenza A/H1N1 pandemic. Prim Care Respir J 2011; 20(4):421–426. doi:10.4104/pcrj.2011.00067
    OpenUrlCrossRefPubMed
  10. ↵
    1. Allyn PR,
    2. Duffy EL,
    3. Humphries RM, et al
    . Graft loss and CLAD-onset is hastened by viral pneumonia after lung transplantation. Transplantation 2016; 100(11):2424–2431. doi:10.1097/TP.0000000000001346
    OpenUrlCrossRef
  11. ↵
    1. Dierickx D,
    2. Habermann TM
    . Post-transplantation lymphoproliferative disorders in adults. N Engl J Med 2018; 378(6):549–562. doi:10.1056/NEJMra1702693
    OpenUrlCrossRefPubMed
  12. ↵
    1. Kremer BE,
    2. Reshef R,
    3. Misleh JG, et al
    . Post-transplant lymphoproliferative disorder after lung transplantation: a review of 35 cases. J Heart Lung Transplant 2012; 31(3):296–304. doi:10.1016/j.healun.2011.10.013
    OpenUrlCrossRefPubMed
  13. ↵
    1. Kumarasinghe G,
    2. Lavee O,
    3. Parker A, et al
    . Post-transplant lymphoproliferative disease in heart and lung transplantation: defining risk and prognostic factors. J Heart Lung Transplant 2015; 34(11):1406–1414. doi:10.1016/j.healun.2015.05.021
    OpenUrlCrossRef
    1. Cockfield SM
    . Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transpl Infect Dis 2001; 3(2):70–78. doi:10.1034/j.1399-3062.2001.003002070.x
    OpenUrlCrossRefPubMed
  14. ↵
    1. Minárovits J,
    2. Niller H
    . Epstein Barr Virus: Methods and Protocols. Totowa, NJ: Humana Press; 2016.
  15. ↵
    1. Luskin MR,
    2. Heil DS,
    3. Tan KS, et al
    . The impact of EBV status on characteristics and outcomes of posttransplantation lymphoproliferative disorder. Am J Transplant 2015; 15(10):2665–2673. doi:10.1111/ajt.13324
    OpenUrlCrossRefPubMed
  16. ↵
    1. Cao S,
    2. Cox KL,
    3. Berquist W, et al
    . Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus. Pediatr Transplant 1999; 3(1):22–26. doi:10.1034/j.1399-3046.1999.00002.x
    OpenUrlCrossRefPubMed
  17. ↵
    1. McKeage K,
    2. McCormack PL
    . Basiliximab: a review of its use as induction therapy in renal transplantation. BioDrugs 2010; 24(1):55–76. doi:10.2165/11203990-000000000-00000
    OpenUrlCrossRefPubMed
  18. ↵
    1. Humar A,
    2. Mazzulli T,
    3. Moussa G, et al
    . Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+/R- transplant recipients. Am J Transplant 2005; 5(5):1065–1070. doi:10.1111/j.1600-6143.2005.00797.x
    OpenUrlCrossRefPubMed
  19. ↵
    1. Maylin S,
    2. Feghoul L,
    3. Salmona M, et al
    . Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation. J Med Virol 2017; 89(11):2003–2010. doi:10.1002/jmv.24889
    OpenUrlCrossRef
  20. ↵
    1. Epstein MA,
    2. Achong BG,
    3. Barr YM
    . Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1964; 1(7335):702–703. doi:10.1016/s0140-6736(64)91524-7
    OpenUrlCrossRefPubMed
  21. ↵
    1. Crawford D,
    2. Johannessen I,
    3. Rickinson AB
    . Cancer Virus: The Story of Epstein-Barr Virus. New York, NY: Oxford University Press; 2014.
    1. Pope JH,
    2. Horne MK,
    3. Scott W
    . Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus. Int J Cancer 1968; 3(6):857–866. doi:10.1002/ijc.2910030619
    OpenUrlCrossRefPubMed
  22. ↵
    1. Penn I,
    2. Hammond W,
    3. Brettschneider L,
    4. Starzl TE
    . Malignant lymphomas in transplantation patients. Transplant Proc 1969; 1(1):106–112. pmid:4944206
    OpenUrlPubMed
  23. ↵
    1. Bow EJ,
    2. Evans G,
    3. Fuller J, et al
    . Canadian clinical practice guidelines for invasive candidiasis in adults. Can J Infect Dis Med Microbiol 2010; 21(4):e122–e150. doi:10.1155/2010/357076
    OpenUrlCrossRefPubMed
    1. Marchetti O,
    2. Cordonnier C,
    3. Calandra T
    . Empirical antifungal therapy in neutropaenic cancer patients with persistent fever. Eur J Cancer Suppl 2007; 5(2):32–42. doi:10.1016/j.ejcsup.2007.06.005
    OpenUrlCrossRef
  24. ↵
    1. Taplitz RA,
    2. Kennedy EB,
    3. Bow EJ, et al
    . Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update. J Clin Oncol 2018; 36(14):1443–1453. doi:10.1200/JCO.2017.77.6211
    OpenUrlCrossRefPubMed
  25. ↵
    1. Green M,
    2. Michaels MG
    . Epstein-Barr virus infection and posttransplant lymphoproliferative disorder. Am J Transplant 2013; 13(suppl 3):41–54. doi:10.1111/ajt.12004
    OpenUrlCrossRefPubMed
  26. ↵
    1. Span AH,
    2. van Dam-Mieras MC,
    3. Mullers W,
    4. Endert J,
    5. Muller AD,
    6. Bruggeman CA
    . The effect of virus infection on the adherence of leukocytes or platelets to endothelial cells. Eur J Clin Invest 1991; 21(3):331–338. doi:10.1111/j.1365-2362.1991.tb01378.x
    OpenUrlCrossRefPubMed
  27. ↵
    1. Tsai DE,
    2. Hardy CL,
    3. Tomaszewski JE, et al
    . Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients. Transplantation 2001; 71(8):1076–1088. doi:10.1097/00007890-200104270-00012
    OpenUrlCrossRefPubMed
  28. ↵
    1. Dharnidharka VR,
    2. Mohanakumar T
    . New approaches to treating B-cell cancers induced by Epstein-Barr virus. N Engl J Med 2015; 372(6):569–571. doi:10.1056/NEJMcibr1415117
    OpenUrlCrossRef
  29. ↵
    1. Oertel SH,
    2. Verschuuren E,
    3. Reinke P, et al
    . Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD). Am J Transplant 2005; 5(12):2901–2906. doi:10.1111/j.1600-6143.2005.01098.x
    OpenUrlCrossRefPubMed
  30. ↵
    1. Mendogni P,
    2. Henchi S,
    3. Morlacchi LC, et al
    . Epstein-Barr virus-related post-transplant lymphoproliferative disorders in cystic fibrosis lung transplant recipients: a case series. Transplant Proc 2019; 51(1):194–197. doi:10.1016/j.transproceed.2018.05.032
    OpenUrlCrossRef
  31. ↵
    1. Kinch A,
    2. Baecklund E,
    3. Backlin C, et al
    . A population-based study of 135 lymphomas after solid organ transplantation: the role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival. Acta Oncol 2014; 53(5):669–679. doi:10.3109/0284186X.2013.844853
    OpenUrlCrossRefPubMed
  32. ↵
    1. Ison MG,
    2. Grossi P; AST Infectious Diseases Community of Practice
    . Donor-derived infections in solid organ transplantation. Am J Transplant 2013; 13(suppl 4):22–30. doi:10.1111/ajt.12095
    OpenUrlCrossRefPubMed

This article requires you to have a ccjm.org account to view the full text. If you already have an account, you may log in below to view this article along with all other CCJM content. If you do not have an account, register here. It’s free!

Log in using your username and password

Forgot your user name or password?
PreviousNext
Back to top

Registration is Now Required for Free Access to CCJM Content

Register once and log in for full access to articles and content. Click “Register” in the upper right corner and follow the simple instructions to create a new account.

If you are using a mobile device, click on the settings icon to access the Register link.

In this issue

Cleveland Clinic Journal of Medicine: 87 (12)
Cleveland Clinic Journal of Medicine
Vol. 87, Issue 12
1 Dec 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Fever in a lung transplant recipient
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Fever in a lung transplant recipient
Graham Walter, Hanna Lyubetska, Aditya Sharma
Cleveland Clinic Journal of Medicine Dec 2020, 87 (12) 735-741; DOI: 10.3949/ccjm.87a.19132

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Fever in a lung transplant recipient
Graham Walter, Hanna Lyubetska, Aditya Sharma
Cleveland Clinic Journal of Medicine Dec 2020, 87 (12) 735-741; DOI: 10.3949/ccjm.87a.19132
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • INITIAL EVALUATION
    • DIFFERENTIAL DIAGNOSIS
    • CASE CONTINUED: SPLENOMEGALY, PERSISTENT CYTOPENIAS
    • FURTHER INVESTIGATION AND MANAGEMENT
    • THE ROLE OF EBV IN PTLD
    • DEFINITIVE MANAGEMENT
    • CASE CONCLUSION
    • SALIENT POINTS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Acute pancreatitis secondary to hypertriglyceridemia
  • Peripheral artery disease and unusual skin findings
Show more Symptoms to Diagnosis

Similar Articles

Subjects

  • Oncology
  • Pulmonology
  • Hematology
  • Drug Therapy
  • Allergy/Immunology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit
  • Advertise Contact

Info For

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • Advertisers
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2021 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire